Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.8664 per EA under NDC 00093500556. Its NADAC has been published 480 times since Apr 19, 2017.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5
Olmesartan Medoxomil, Amlodipine and HydrochlorothiazideStrength
5; 12.5; 20 mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093500556
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA202491On Market Since
11/14/2016
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has been published 480 times since Apr 19, 2017, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8664 per EA |
|---|---|
| All-time high | $2.7845 (Dec 13, 2017) |
| All-time low | $0.8629 (Mar 18, 2026) |
| 52-week high | $1.0446 |
| 52-week low | $0.8629 |
| Median price | $1.3860 |
| Average price | $1.4930 |
| Largest weekly change | +49.6% (May 22, 2019) |
| Weeks tracked | 480 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5, manufactured by Teva Pharmaceuticals USA Inc., is $0.8664 per EA (NDC 00093500556), effective Jun 24, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has declined 66.4%. It has been tracked across 480 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
Since Apr 19, 2017, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has ranged from a low of $0.8629 (Mar 18, 2026) to a high of $2.7845 (Dec 13, 2017), with a median of $1.3860 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5, so no direct lower-cost alternative is listed.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 (NDC 00093500556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification